Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Wegovy Pill Becomes Available
In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, clears a new therapy to prev…
4 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Wegovy Pill
In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears Roche’s Lunsumio Velo fo…
4 months, 4 weeks ago
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
In today’s Pharmaceutical Executive Daily, President Trump announces nine additional participants in the TrumpRx program, AstraZeneca reaches a $2 bi…
4 months, 4 weeks ago
Scaling Sustainability: A Big Pharma Formula
In this enlightening conversation with Pharm Exec, Jim Greffet, VP of sustainability at Eli Lilly, unpacks how environmental, social, and governance …
4 months, 4 weeks ago
Pharmaceutical Executive Daily: US Senate Passes Biosecure Act
In today’s Pharmaceutical Executive Daily, Eli Lilly announces positive topline Phase III data for its oral GLP-1 candidate orforglipron, the U.S. Se…
5 months ago
Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release
In today’s Pharmaceutical Executive Daily, Pfizer discloses its 2026 revenue expectations, a bipartisan group of House Republicans moves to force a v…
5 months ago
Pharmaceutical Executive Daily: FDA's Approval of Lerochol
In today’s Pharmaceutical Executive Daily, the FDA approves a new LDL-lowering therapy, Sanofi announces two strategic deals spanning Alzheimer’s dis…
5 months ago
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
In today’s Pharmaceutical Executive Daily, new analysis highlights access gaps in the TrumpRx framework, the FDA awards a national priority voucher t…
5 months ago
Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results
In today’s Pharmaceutical Executive Daily, Eli Lilly reports positive topline Phase III results for retatrutide, the FDA expands Amgen’s Uplizna labe…
5 months ago
Pharmaceutical Executive Daily: FDA's Approval of Waskyra
In today’s Pharmaceutical Executive Daily, new analysis outlines what it may truly cost to fix the biopharma ecosystem, the FDA approves Waskyra for …
5 months, 1 week ago